Immunogenicity of Biologics, Biopharmaceuticals & ATMPs
6 6 people viewed this event.
This live online training course provides practical insights into immunogenicity assessment, anti-drug antibodies (ADA), bioanalytical methods, regulatory requirements, and risk mitigation strategies for biologics, biopharmaceuticals, biosimilars, vaccines, and ATMPs. Led by renowned industry experts, participants will explore preclinical and clinical considerations, assay development, quality control, and global regulatory expectations. The program includes case studies, interactive discussions, and expert guidance to help professionals manage immunogenicity challenges effectively throughout product development.
Event Organizer: Fleming Events